Icariin (ICA), a flavonoid glycoside extracted from the traditional Chinese medicine Epimedium, can play a therapeutic role in the treatment of SSc by alleviating the symptoms of SSc through the targeted inhibition of the JNK/NF-κB autophagy-related signaling pathway (225). This evidence concerns the gene MAPK8 and systemic sclerosis.